CA2801969C - Dispositif de fermeture de lesion vasculaire - Google Patents

Dispositif de fermeture de lesion vasculaire Download PDF

Info

Publication number: CA2801969C
Authority: CA; Canada
Prior art keywords: delivery tube; catheter; pusher member; tube; chamber
Prior art date: 2003-08-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA2801969A

Other languages

English (en)

Other versions

CA2801969A1 (fr

Inventor

Yong Hua Zhu

Wolff M. Kirsch

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Loma Linda University

Original Assignee

Loma Linda University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-08-14

Filing date

2004-08-16

Publication date

2015-02-24

2004-08-16 Application filed by Loma Linda University filed Critical Loma Linda University

2004-08-16 Priority claimed from CA2535452A external-priority patent/CA2535452C/fr

2005-02-24 Publication of CA2801969A1 publication Critical patent/CA2801969A1/fr

2015-02-24 Application granted granted Critical

2015-02-24 Publication of CA2801969C publication Critical patent/CA2801969C/fr

2024-08-16 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

230000002792 vascular Effects 0.000 title abstract description 41
239000000463 material Substances 0.000 claims abstract description 99
229920001661 Chitosan Polymers 0.000 claims description 19
238000007906 compression Methods 0.000 claims description 10
230000006835 compression Effects 0.000 claims description 10
239000003814 drug Substances 0.000 claims description 7
238000007920 subcutaneous administration Methods 0.000 claims description 7
229940124597 therapeutic agent Drugs 0.000 claims description 2
206010052428 Wound Diseases 0.000 abstract description 127
208000027418 Wounds and injury Diseases 0.000 abstract description 100
230000002439 hemostatic effect Effects 0.000 abstract description 65
210000004369 blood Anatomy 0.000 abstract description 23
239000008280 blood Substances 0.000 abstract description 23
239000002874 hemostatic agent Substances 0.000 abstract description 20
229940030225 antihemorrhagics Drugs 0.000 abstract description 19
230000023555 blood coagulation Effects 0.000 abstract description 8
230000035602 clotting Effects 0.000 abstract description 7
230000008878 coupling Effects 0.000 description 115
238000010168 coupling process Methods 0.000 description 115
238000005859 coupling reaction Methods 0.000 description 115
239000000853 adhesive Substances 0.000 description 36
230000001070 adhesive effect Effects 0.000 description 36
210000004204 blood vessel Anatomy 0.000 description 27
229940045110 chitosan Drugs 0.000 description 18
210000001367 artery Anatomy 0.000 description 14
239000000758 substrate Substances 0.000 description 14
238000000034 method Methods 0.000 description 12
229920002101 Chitin Polymers 0.000 description 8
238000002399 angioplasty Methods 0.000 description 8
239000003795 chemical substances by application Substances 0.000 description 8
210000001105 femoral artery Anatomy 0.000 description 8
239000004005 microsphere Substances 0.000 description 8
230000008901 benefit Effects 0.000 description 6
230000000740 bleeding effect Effects 0.000 description 6
230000000295 complement effect Effects 0.000 description 6
230000007246 mechanism Effects 0.000 description 6
230000007704 transition Effects 0.000 description 6
230000017531 blood circulation Effects 0.000 description 5
239000012530 fluid Substances 0.000 description 5
0 CCCCC=C1*CCC*1 Chemical compound CCCCC=C1*CCC*1 0.000 description 4
102000008186 Collagen Human genes 0.000 description 4
108010035532 Collagen Proteins 0.000 description 4
108090000190 Thrombin Proteins 0.000 description 4
210000001124 body fluid Anatomy 0.000 description 4
229920001436 collagen Polymers 0.000 description 4
229940079593 drug Drugs 0.000 description 4
230000009969 flowable effect Effects 0.000 description 4
150000004676 glycans Chemical class 0.000 description 4
239000002245 particle Substances 0.000 description 4
229920001282 polysaccharide Polymers 0.000 description 4
239000005017 polysaccharide Substances 0.000 description 4
238000007789 sealing Methods 0.000 description 4
239000007858 starting material Substances 0.000 description 4
229960004072 thrombin Drugs 0.000 description 4
206010053567 Coagulopathies Diseases 0.000 description 3
108010073385 Fibrin Proteins 0.000 description 3
102000009123 Fibrin Human genes 0.000 description 3
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
230000003466 anti-cipated effect Effects 0.000 description 3
210000001772 blood platelet Anatomy 0.000 description 3
229920002678 cellulose Polymers 0.000 description 3
239000001913 cellulose Substances 0.000 description 3
239000011248 coating agent Substances 0.000 description 3
238000000576 coating method Methods 0.000 description 3
239000004744 fabric Substances 0.000 description 3
229950003499 fibrin Drugs 0.000 description 3
230000008569 process Effects 0.000 description 3
238000001356 surgical procedure Methods 0.000 description 3
210000005166 vasculature Anatomy 0.000 description 3
125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
208000009087 False Aneurysm Diseases 0.000 description 2
208000031481 Pathologic Constriction Diseases 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
230000003110 anti-inflammatory effect Effects 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
239000002131 composite material Substances 0.000 description 2
210000004351 coronary vessel Anatomy 0.000 description 2
239000013013 elastic material Substances 0.000 description 2
239000002657 fibrous material Substances 0.000 description 2
230000035876 healing Effects 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000002483 medication Methods 0.000 description 2
239000000203 mixture Substances 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
239000000843 powder Substances 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
208000037804 stenosis Diseases 0.000 description 2
230000036262 stenosis Effects 0.000 description 2
239000012780 transparent material Substances 0.000 description 2
238000007631 vascular surgery Methods 0.000 description 2
108091005508 Acid proteases Proteins 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
241000796533 Arna Species 0.000 description 1
108010039209 Blood Coagulation Factors Proteins 0.000 description 1
102000015081 Blood Coagulation Factors Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
108010059892 Cellulase Proteins 0.000 description 1
241000238557 Decapoda Species 0.000 description 1
108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
108010049003 Fibrinogen Proteins 0.000 description 1
102000008946 Fibrinogen Human genes 0.000 description 1
HOKDBMAJZXIPGC-UHFFFAOYSA-N Mequitazine Chemical compound C12=CC=CC=C2SC2=CC=CC=C2N1CC1C(CC2)CCN2C1 HOKDBMAJZXIPGC-UHFFFAOYSA-N 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
208000018262 Peripheral vascular disease Diseases 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
239000004365 Protease Substances 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
239000004830 Super Glue Substances 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
206010048975 Vascular pseudoaneurysm Diseases 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000009471 action Effects 0.000 description 1
230000001760 anti-analgesic effect Effects 0.000 description 1
210000000436 anus Anatomy 0.000 description 1
239000011324 bead Substances 0.000 description 1
238000005452 bending Methods 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
229920001222 biopolymer Polymers 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000003114 blood coagulation factor Substances 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
229940106157 cellulase Drugs 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
FLASNYPZGWUPSU-SICDJOISSA-N chitosan Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)N)O[C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)N)O[C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)N)O[C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)N)O[C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)N)O[C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H](O[C@@H](O[C@@H]2[C@H](O[C@@H](O)[C@H](N)[C@H]2O)CO)[C@H](N)[C@H]1O)CO)NC(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1N FLASNYPZGWUPSU-SICDJOISSA-N 0.000 description 1
108010089807 chitosanase Proteins 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000007887 coronary angioplasty Methods 0.000 description 1
230000006196 deacetylation Effects 0.000 description 1
238000003381 deacetylation reaction Methods 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000000151 deposition Methods 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000009826 distribution Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
239000000835 fiber Substances 0.000 description 1
229940012952 fibrinogen Drugs 0.000 description 1
238000009472 formulation Methods 0.000 description 1
230000004927 fusion Effects 0.000 description 1
238000002695 general anesthesia Methods 0.000 description 1
231100001261 hazardous Toxicity 0.000 description 1
230000023597 hemostasis Effects 0.000 description 1
239000008240 homogeneous mixture Substances 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 1
230000000774 hypoallergenic effect Effects 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
238000001746 injection moulding Methods 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
229940127554 medical product Drugs 0.000 description 1
239000012528 membrane Substances 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
239000002808 molecular sieve Substances 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
238000005457 optimization Methods 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
239000004033 plastic Substances 0.000 description 1
231100000614 poison Toxicity 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
-1 polypropylene Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000000979 retarding effect Effects 0.000 description 1
230000000250 revascularization Effects 0.000 description 1
239000000565 sealant Substances 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000002791 soaking Methods 0.000 description 1
URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
239000002993 sponge (artificial) Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
230000002966 stenotic effect Effects 0.000 description 1
239000000126 substance Substances 0.000 description 1
230000003746 surface roughness Effects 0.000 description 1
210000000779 thoracic wall Anatomy 0.000 description 1
229940033618 tisseel Drugs 0.000 description 1
239000003440 toxic substance Substances 0.000 description 1
230000000472 traumatic effect Effects 0.000 description 1
239000002699 waste material Substances 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
230000029663 wound healing Effects 0.000 description 1

Landscapes

Surgical Instruments (AREA)

CA2801969A 2003-08-14 2004-08-16 Dispositif de fermeture de lesion vasculaire Expired - Fee Related CA2801969C (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US49542403P	2003-08-14	2003-08-14
US60/495,424		2003-08-14
US54715404P	2004-02-23	2004-02-23
US60/547,154		2004-02-23
CA2535452A CA2535452C (fr)	2003-08-14	2004-08-16	Dispositif de fermeture de lesion vasculaire

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2535452A Division CA2535452C (fr)	2003-08-14	2004-08-16	Dispositif de fermeture de lesion vasculaire

Publications (2)

Publication Number	Publication Date
CA2801969A1 CA2801969A1 (fr)	2005-02-24
CA2801969C true CA2801969C (fr)	2015-02-24

Family

ID=37003240

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2801969A Expired - Fee Related CA2801969C (fr)	2003-08-14	2004-08-16	Dispositif de fermeture de lesion vasculaire

Country Status (2)

Country	Link
CN (1)	CN100374083C (fr)
CA (1)	CA2801969C (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6404584B2 (ja) *	2014-03-26	2018-10-10	オリンパス株式会社	ステントデリバリーシステム
ES2774936T3 (es) *	2014-07-04	2020-07-23	Abiomed Europe Gmbh	Vaina para el acceso estanco a un vaso
CN107669302A (zh) *	2017-11-03	2018-02-09	韩宗霖	一种用于血管外科手术的封堵器械
CN113041427A (zh) *	2021-03-10	2021-06-29	天琴亼丝微医疗器械技术(苏州)有限公司	一种全向注冲导管

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4738658A (en) *	1986-09-19	1988-04-19	Aries Medical Incorporated	Tapered hemostatic device for use in conjunction with a catheter for alleviating blood leakage and method for using same
US6056768A (en) *	1992-01-07	2000-05-02	Cates; Christopher U.	Blood vessel sealing system
WO2002005865A2 (fr) *	2000-07-14	2002-01-24	Sub-Q, Inc.	Dispositif monte sur gaine pour mise en place d'un bouchon arteriel
CN2436105Y (zh) *	2000-08-31	2001-06-27	蒲忠杰	微型伤口封闭器

2004
- 2004-08-16 CN CNB200480023342XA patent/CN100374083C/zh not_active Expired - Fee Related
- 2004-08-16 CA CA2801969A patent/CA2801969C/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN100374083C (zh)	2008-03-12
CN1835715A (zh)	2006-09-20
CA2801969A1 (fr)	2005-02-24

Legal Events

Date	Code	Title	Description
2013-02-07	EEER	Examination request	Effective date: 20130110
2018-09-27	MKLA	Lapsed	Effective date: 20180816

Publication	Publication Date	Title
CA2535452C (fr)	2013-04-02	Dispositif de fermeture de lesion vasculaire
CA2488751C (fr)	2012-04-17	Dispositif et procede d'occlusion de blessure vasculaire
US8088145B2 (en)	2012-01-03	Vascular wound closure device and method
CN100374083C (zh)	2008-03-12	用于皮下输送物质的装置
AU2011218678B2 (en)	2012-04-12	Vascular Wound Closure Device